Locally acting therapies are like a religion to Flexion Therapeutics (NSDQ:FLXN) co-founder & CEO Dr. Mike Clayman, who spent decades at Eli Lilly (NYSE:LLY) with the company’s co-founder, Dr. Neil Bodick, watching promising compounds fail in late-stage trials on the heels of unanticipated safety results. “That’s part of the reason, not the whole reason but part of the reason, […]
(Reuters) — Genzyme agreed to pay $32.59 million, admit wrongdoing and enter a deferred prosecution agreement to resolve criminal charges over its marketing of the surgical implant Seprafilm, the U.S. Justice Dept. said yesterday. The biotechnology unit of French drug company Sanofi (NYSE:SNY) was accused of 2 misdemeanor counts of violating the federal Food, Drug and Cosmetic Act from […]
(Reuters) — Consumer watchdog Public Citizen said it petitioned the FDA to withdraw approval of Sanofi‘s (NYSE:SNY) Seprafilm and order a recall, saying the surgical implant has been associated with side effects including death. Seprafilm, developed by Sanofi subsidiary Genzyme, is used to reduce abnormal internal scarring following surgery, by separating tissues and organs while they […]
Diagnostics technologies and lab services company Laboratory Corp. of America Holdings (NYSE:LH) announced a definitive agreement to acquire Clearstone Central Laboratories to boost the company’s capabilities and global reach providing services for clinical trials.
Burlington, N.C.-based LabCorp announced the definitive agreement on Wednesday, though the company did not disclose any financial terms of its proposed acquisition of privately held Clearstone.
The companies expect to close the deal later this quarter.
A roundup of companies announcing mergers and acquisitions.
NeuroMetrix Inc. (NSDQ:NURO) and two other companies re-paid tax incentives to Massachusetts after failing to create enough jobs to meet the demands of the deal through which the funding came.
The Waltham, Mass.-based company, which has suffered sinking revenues over the past year, voluntarily surrendered the $300,000 that it procured through the Mass. Life Sciences Center’s $25 million Tax Incentive Program in late 2009, according to a center spokesman.
Study shows many women skip mammograms. Despite the uproar over mammography guideline changes, many women still skip screenings, according to a Medco Health Solutions study of utilization in more than 1.5 million women, reports MedPage Today.